Dr. Michael R. Zile

Dr. Daniel Judge is a professor of medicine in cardiology at MUSC. He received his medical degree at the University of Pennsylvania, and did his post-graduate training in internal medicine, cardiology, and advanced heart failure/transplant cardiology at Johns Hopkins. He is board-certified in both cardiology and advanced heart failure/transplant cardiology.Dr. Judge takes care of adult patients with inherited forms of cardiovascular disease, as well as congestive heart failure. As director of the cardiovascular genetics program, Dr. Judge has extensive experience caring for individuals and families with inherited forms of cardiomyopathy, aortic aneurysm, amyloidosis, and cardiac involvement from other genetic conditions.He has authored more than 150 scientific manuscripts. Dr. Judge is highly rated in 23 conditions, according to our data. His top areas of expertise are Cardiomyopathy, Transthyretin Amyloid Cardiomyopathy, Cardiac Amyloidosis, Heart Transplant, and Cardiac Ablation.

Dr. Tedford is a Professor of Medicine/Cardiology and holds the Dr. Peter C. Gazes Endowed Chair in Heart Failure at the Medical University of South Carolina (MUSC) in Charleston, SC. He currently serves as the section head of heart failure and medical director of cardiac transplantation. He also established and directs the Advanced Heart Failure and Transplant Fellowship Program at MUSC. Dr. Tedford is an internationally recognized clinical researcher and has published over 200 peer-reviewed original research manuscripts, invited expert reviews, editorials and book chapters. His research efforts are focused on hemodynamic assessment of right ventricle function and its interaction with the pulmonary circulation and left heart. This research spans the fields of pulmonary hypertension, left heart disease, exercise physiology, hemodynamics, systemic sclerosis and mechanical circulatory support. He participates on several scientific advisory boards, clinical trial steering committees, and serves as a hemodynamic core laboratory for clinical pharmaceutical trials. He is co-chair of the PH due to left heart disease task force for 7^th^ World Symposium on Pulmonary Hypertension. He is a deputy editor for the *Journal of Heart and Lung Transplantation* and serves on the editorial board for *Circulation: Heart Failure CHEST*and *JACC: Heart* *Failure.*. Dr. Tedford is highly rated in 14 conditions, according to our data. His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Pulmonary Hypertension, Heart Failure, Heart Transplant, and Cardiac Ablation.

Dr. Sheldon E. Litwin is a cardiologist with nationally recognized expertise in advanced cardiac imaging and its use in the diagnosis of heart disease and treatment of patients with heart disease. Dr. Litwin is board-certified in general cardiology, nuclear cardiology, echocardiography, and cardiovascular computed tomography (CT). He was recognized in 2014 in America's Top Doctors (Castle Connolly Medical Ltd.). He is a strong proponent of preventive cardiology and has a longstanding interest in weight loss as prevention and treatment for cardiovascular disease. He is an avid outdoorsman and exercise advocate who is passionate about caring for active adults who participate in sports or recreational exercise. Prior to coming to MUSC Health, Dr. Litwin was chief of the division of cardiology at Georgia Regents University from 2011 to 2014 and director of cardiac imaging at the University of Utah from 1993 to 2011. Dr. Litwin is involved in clinical trials using new therapies for heart failure with preserved ejection fraction (HFpEF). He has published more than 100 scientific papers and serves on several editorial boards and national committees.Dr. Litwin's medical degree was awarded by Washington University School of Medicine. He completed a residency at the University of Arizona and completed a cardiology fellowship at Beth Israel Hospital, Harvard Medical School. Dr. Litwin is highly rated in 15 conditions, according to our data. His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Cardiomyopathy, Gastric Bypass, and Cardiac Ablation.